PRIMARY HYPERLIPIDEMIA Clinical Trials

7 clinical trials for PRIMARY HYPERLIPIDEMIA across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Zhibitai Capsules for the Treatment of Primary Hyperlipidemia — RECRUITING · PHASE2
• A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid — RECRUITING · PHASE3
• A 52 WEEK, PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS. SPIRE-LL: STUDIES OF PCSK9 INHIBITION AND THE REDUCTION OF VASCULAR EVENTS - LIPID LOWERING — RECRUITING · PHASE3
• A PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR DYSLIPDEMIA AT RISK OF CARDIOVASCULAR EVENTS — RECRUITING · PHASE3
• "A MULTICENTER, CONTROLLED, OPEN-LABEL EXTENSION (OLE) STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF AMG 145." — RECRUITING
• A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid — NOT_YET_RECRUITING · PHASE3
• A PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, LONG-TERM SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS — COMPLETED · PHASE3

Refine this search